Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder

(MedPage Today) -- The FDA approved adrabetadex (Lembaz) injection on Tuesday for patients with infantile-onset Niemann-Pick disease type C (NPC), a rare and fatal genetic disorder. Indicated for adults and children weighing at least 15 lb whose...

FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Wednesday 18 November →